文献速递甲状腺疾病

Oatp1c1缺陷中的神经改变与下丘脑-垂体-甲状腺轴功能亢进

Neural Alterations and Hyperactivity of the Hypothalamic-Pituitary-Thyroid Axis in Oatp1c1 Deficiency.
PubMed 文献 · Thyroid · 2020-01-01

该研究建立了 oatp1c1 基因敲除斑马鱼模型以探究 OATP1C1 缺陷机制。突变幼鱼下丘脑-垂体-甲状腺轴活性及运动行为增加,放射状胶质细胞结构改变、神经元轴突缩短,成鱼甲状腺肿大。甲状腺激素类似物(而非甲状腺激素)可缩小突变成鱼甲状腺并改善其颜色。

要点

  • oatp1c1 在斑马鱼内皮细胞、神经元和星形胶质细胞中表达。
  • oatp1c1-/- 幼鱼下丘脑-垂体-甲状腺轴活性及运动行为增加。
  • 甲状腺激素类似物可缩小 oatp1c1-/- 成鱼甲状腺并改善颜色。

核心结论

  • Oatp1c1 缺陷斑马鱼模型再现了 OATP1C1 缺陷患者的内分泌、神经和行为改变。
  • 甲状腺激素类似物在 oatp1c1-/- 斑马鱼模型中的疗效可能为人类患者提供治疗方向。

研究设计与样本

  • 研究建立了 oatp1c1 基因敲除(oatp1c1-/-)斑马鱼模型。
  • 研究对象包括 oatp1c1-/- 幼鱼与成鱼,以及 oatp1c1-/-Xmct8-/- 成鱼。

主要发现

  • oatp1c1 在斑马鱼内皮细胞、神经元和星形胶质细胞中表达。
  • oatp1c1-/- 幼鱼下丘脑-垂体-甲状腺轴活性及行为运动活性增加。
  • 神经病理分析显示 oatp1c1-/- 幼鱼和成鱼放射状胶质细胞结构改变、神经元轴突缩短。
  • oatp1c1-/- 与 oatp1c1-/-Xmct8-/- 成鱼均出现甲状腺肿大。
  • 药理学实验显示甲状腺激素类似物而非甲状腺激素可缩小 oatp1c1-/- 成鱼甲状腺并改善其颜色。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The thyroid hormones (THs) triiodothyronine (T3) and thyroxine (T4) are crucial regulators of brain development and function. Cell-specific transporter proteins facilitate TH uptake and efflux across the cell membrane, and insufficient TH transport causes hypothyroidism and mental retardation. Mutations in the TH transporters monocarboxylate transporter 8 (MCT8, SLC16A2) and the organic anion-transporting polypeptide 1C1 (OATP1C1, SLCO1C1) are associated with the psychomotor retardation Allan-Herndon-Dudley syndrome and juvenile neurodegeneration, respectively. Methods: To understand the mechanisms and test potential treatments for the recently discovered OATP1C1 deficiency, we established an oatp1c1 mutant (oatp1c1-/-) zebrafish. Results:oatp1c1 is expressed in endothelial cells, neurons, and astrocytes in zebrafish. The activity of the hypothalamic-pituitary-thyroid axis and behavioral locomotor activity increased in oatp1c1-/- larvae. Neuropathological analysis revealed structural alteration in radial glial cells and shorter neuronal axons in oatp1c1-/- larvae and adults. Notably, oatp1c1-/- and oatp1c1-/-Xmct8-/- adults exhibit an enlarged thyroid gland (goiter). Pharmacological assays showed that TH analogs, but not THs, can reduce the size and improve the color of the thyroid gland in adult mutant zebrafish. Conclusion: These results establish a vertebrate model for OATP1C1 deficiency that demonstrates endocrinological, neurological, and behavioral alterations mimicking findings observed in an OATP1C1-deficient patient. Further, the curative effect of TH analogs in the oatp1c1-/- zebrafish model may provide a lead toward a treatment modality in human patients.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Admati I, Wasserman-Bartov T, Tovin A, et al. Neural Alterations and Hyperactivity of the Hypothalamic-Pituitary-Thyroid Axis in Oatp1c1 Deficiency. Thyroid. 2020. PMID: 31797746. doi:10.1089/thy.2019.0320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。